Development of Trypsin Resistant Pan Reactive Trypsin Antibodies

Home » Technology » New Technologies » Technologies in Health » Development of Trypsin Resistant Pan Reactive Trypsin Antibodies


Enzyme trypsin is widely used in various biological processes such as Insulin manufacturing to cleave peptide linkers from the pro-drug C peptide removal from Proinsulin and activation of vaccine viruses. Residual trypsin analysis is used during downstream processing.


Stage of Development


Commercialization. In the past 14 months, they have been successful in immunization of trypsin to elicit immune response in Rabbits and Mice to various epitopes spanning the trypsin enzymes, optimized purification strategies to isolate trypsin resistant anti-trypsin pAb and mAb and developed immunoassay reagents and demonstrated the assay utility for monitoring trypsin clearance during bioprocessing of Biologics Eg: Insulin manufacturing.


Unique Features of The Product/Technology


The kits are customized for end users to meet global regulatory requirements. Niche product developed for Insulin manufacturers.


Market Potential


Potential therapeutic anti-trypsin engineered antibody drug for treating Pancreatitis is an unmet medical need.


National/Societal Relevance


Anti-trypsin antibodies and immunoassay developed by Affigenix enables drug companies to monitor the clearance of the trypsin used in downstream processing of Biologics and Biosimilar.


For further information please contact


Biotechnology Industry Research Assistance Council (BIRAC)

1 st Floor, MTNL Building, 9, CGO Complex,

Lodhi Road, New Delhi- 110003

Phone: + 91-11-24389600